GT Biopharma, Inc.
GTBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000109657
No open-market purchases or sales by GT Biopharma, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $1.02M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in GT Biopharma, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −13 vs. Q2 2022
- Shares held
- 2.48M
- −626.9K (−20.2%) vs. Q2 2022
- Total value
- $4.36M
- −$4.92M (−53.0%) vs. Q2 2022
- New holders
- 2
- 7 more added
- Sold out
- 15
- 15 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GTBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $1.02M |
| Q1 2026 | 42 | $656.7K |
| Q4 2025 | 38 | $373.7K |
| Q3 2025 | 21 | $222.2K |
| Q2 2025 | 21 | $711.3K |
| Q1 2025 | 20 | $220.5K |
| Q4 2024 | 19 | $279.1K |
| Q3 2024 | 16 | $203.8K |
| Q2 2024 | 17 | $296.8K |
| Q1 2024 | 17 | $348.6K |
| Q4 2023 | 34 | $893.1K |
| Q3 2023 | 33 | $849.9K |
| Q2 2023 | 37 | $1.11M |
| Q1 2023 | 36 | $3.05M |
| Q4 2022 | 36 | $5.62M |
| Q3 2022 | 35 | $4.36M |
| Q2 2022 | 48 | $9.28M |
| Q1 2022 | 58 | $12.9M |
| Q4 2021 | 55 | $16.7M |
| Q3 2021 | 54 | $32.1M |
| Q2 2021 | 50 | $69.9M |
| Q1 2021 | 21 | $3.98M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding GT Biopharma, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,126,941 | $1.98M | 0.00% | +1000.0% | Added |
| BlackRock Inc. | 371,778 | $654.0K | 0.00% | −4,776−1.3% | Reduced |
| Geode Capital Management, LLC | 223,908 | $394.0K | 0.00% | −43,396−16.2% | Reduced |
| Millennium Management LLC | 153,979 | $271.0K | 0.00% | −90,201−36.9% | Reduced |
| State Street Corp | 102,776 | $181.0K | 0.00% | +8,700+9.2% | Added |
| Bank of New York Mellon Corp | 95,239 | $167.0K | 0.00% | −3,425−3.5% | Reduced |
| Atria Wealth Solutions, Inc. | 68,720 | $120.9K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 51,740 | $91.0K | 0.00% | −3,485−6.3% | Reduced |
| Compagnie Lombard Odier SCmA | 50,000 | $88.0K | 0.00% | +20,000+66.7% | Added |
| Northern Trust Corp | 32,967 | $58.0K | 0.00% | −6,343−16.1% | Reduced |
| Jane Street Group, LLC | 32,717 | $58.0K | 0.00% | +32,717 | New |
| Goldman Sachs Group Inc | 25,034 | $44.0K | 0.00% | +14,382+135.0% | Added |
| Virtu Financial LLC | 24,864 | $44.0K | 0.00% | +24,864 | New |
| Sigma Planning Corp | 21,395 | $38.0K | 0.00% | −50.0% | Reduced |
| Occudo Quantitative Strategies LP | 17,536 | $31.0K | 0.00% | −3,467−16.5% | Reduced |
| Qube Research & Technologies Ltd | 14,867 | $26.0K | 0.00% | −359−2.4% | Reduced |
| Schonfeld Strategic Advisors LLC | 13,100 | $23.0K | 0.00% | −2,600−16.6% | Reduced |
| Brighton Jones LLC | 11,689 | $21.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 11,169 | $19.0K | 0.00% | 00.0% | Unchanged |
| Welch Group, LLC | 10,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,374 | $9.00K | 0.00% | +1,683+45.6% | Added |
| Morgan Stanley | 3,565 | $5.00K | 0.00% | −130,478−97.3% | Reduced |
| UBS Group AG | 3,170 | $5.00K | 0.00% | +54+1.7% | Added |
| Royal Bank of Canada | 2,068 | $3.00K | 0.00% | +110+5.6% | Added |
| Rockefeller Capital Management L.P. | 1,700 | $2.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 998 | $1.00K | 0.00% | −911−47.7% | Reduced |
| Advisor Group Holdings, Inc. | 1,105 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 546 | $1.00K | 0.00% | −44−7.5% | Reduced |
| Coastal Capital Group, Inc. | 549 | $1.00K | 0.00% | 00.0% | Unchanged |
| Blue Bell Private Wealth Management, LLC | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 14 | $25 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 116 | $0 | 0.00% | −17,388−99.3% | Reduced |
| Credit Suisse AG | 176 | $0 | 0.00% | −9−4.9% | Reduced |
| JPMorgan Chase & Co | 16 | $0 | 0.00% | 00.0% | Unchanged |
| Retirement Group, LLC | 44 | $0 | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −81,100−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −64,701−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −60,977−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −44,507−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −41,282−100.0% | Sold out |
| Gordian Capital Singapore Pte Ltd | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Crumly & Associates Inc. | 0 | $0 | 0.00% | −32,163−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −25,869−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −19,207−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −7,231−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −174−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |